Ansys Chief Executive Officer to Present at the 49th Nasdaq Investor Conference

20 Nov 2023
PITTSBURGH, Nov. 20, 2023 /PRNewswire/ -- ANSYS, Inc. (NASDAQ: ANSS) announced today that Ajei Gopal, president and chief executive officer, will participate in a moderated discussion at the 49th Nasdaq Investor Conference, held in association with Morgan Stanley at the May Fair Hotel in London on Wednesday, December 6, 2023, at 8:30 a.m. ET or 1:30 p.m. GMT. A live audio webcast and archive replay of the event will be available at: / Forward-Looking Statements Statements made live and on the webcast are as of the date of the moderated discussion and Ansys does not assume any obligation to update any statements made live or on the archived webcast. Matters discussed may include forward-looking statements about Ansys's anticipated financial results and growth, as well as about the development of products and markets, which are based on current plans and assumptions. Actual results in future periods may differ materially from those expectations due to a number of risks and uncertainties, including those described from time to time in reports filed by Ansys with the U.S. Securities and Exchange Commission, including Ansys's most recent reports on Form 10-K and 10-Q. / About Ansys Our Mission: Powering Innovation that Drives Human Advancement™ When visionary companies need to know how their world-changing ideas will perform, they close the gap between design and reality with Ansys simulation. For more than 50 years, Ansys software has enabled innovators across industries to push boundaries by using the predictive power of simulation. From sustainable transportation to advanced semiconductors, from satellite systems to life-saving medical devices, the next great leaps in human advancement will be powered by Ansys. Ansys and any and all ANSYS, Inc. brand, product, service and feature names, logos and slogans are registered trademarks or trademarks of ANSYS, Inc. or its subsidiaries in the United States or other countries. All other brand, product, service and feature names or trademarks are the property of their respective owners. ANSS–F / Contacts View original content to download multimedia: SOURCE Ansys Company Codes: NASDAQ-NMS:ANSS
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.